Accord Healthcare
Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
DRUG
REACTION
REPORT
GROWTH’S IN OUR NATURE
Accord Healthcare is one of the fastest growing generic pharmaceutical companies in Ireland and the UK.
Acquiring Actavis Ireland and the UK in 2017 facilitates Accord’s ambition of becoming a top 5 pan-EMEA generics company by 2020 and a leading player in the industry at European level.
TRULY MULTINATIONAL
Accord has one of the most extensive sales, marketing and distribution networks in Europe. Accord now supplies products in close to 65 EMENA markets.
A COMPLETE APPROACH
Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.
EUROPEAN FOCUS
Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.
News
First-of-its-kind, patient-activated, pre-filled injector (PFI) to deliver pegfilgrastim (Pelgraz▼) approved in Europe
Pelgraz is the market-leading biosimilar pegfilgrastim in Ireland
Accord and ADIENNE Enter into Exclusive Distribution Agreement for TEPADINA®
Accord Healthcare Limited (“Accord”) and ADIENNE Pharma & Biotech S.A. (“ADIENNE”) have entered into an exclusive licencing and distribution agreement for the commercialisation of TEPADINA® (thiotepa) 15 mg and 100 mg lyophilized powder for concentrate for solution for infusion.
